Delhi govt carries out 27 raids against fake medicine

The raids were conducted by the drugs control department in coordination with the Delhi Police

The Delhi government has carried out a “large-scale” inspection drive over the past week, conducting 27 raids across the Capital as part of a crackdown on illegal and counterfeit drugs, including cough syrups, officials said on Monday. At least 10 firms were found flouting rules and were allegedly involved in the sale of illegal or spurious medicines.

The raids were conducted by the drugs control department in coordination with the Delhi Police, with teams carrying out late-night inspections at drug trading premises. During the drive, officials said they collected 204 samples of medicines and medical supplies, including around 15 bottles of cough syrup, for further examination.

According to officials aware of the matter, the action followed actionable intelligence received last week regarding the movement of counterfeit and unauthorised medicines in the city. “To bust this racket, six teams were constituted to carry out coordinated raids at multiple locations,” an official said.

Bhagirath Palace, a major hub for medicine wholesale sellers, was the focus of the first phase of inspections conducted on Saturday, during which around 18 firms were checked. The second phase of the drive was carried out on Thursday in Sadar Bazar. “During the Sadar Bazar raid, one firm was found selling medical devices and surgical items without a valid licence, in violation of the Medical Devices Rules,” the official added.

Officials said the samples collected include commonly used seasonal and over-the-counter medicines such as cough syrups, paracetamol, cetirizine, betadine cream and solution, salbutamol syrup, Solvin tablets and other formulations. “All samples have been sent for laboratory testing, and reports are expected within 60 days. Further legal action will be taken based on the findings,” an official said.

Preliminary investigations indicate that the counterfeit medicines were being supplied not only within Delhi but also to neighbouring states and even across borders, pointing to a wider distribution network.

“Ensuring the availability of safe and quality medicines is non-negotiable. We have zero tolerance for spurious, substandard or illegally sold drugs and medical devices,” health minister Pankaj Kumar Singh said, adding that enforcement drives will continue across the city to protect public health and deter offenders.

Related Posts

Over 9,000 deaths due to respiratory diseases in Delhi

New Delhi:  The national capital recorded 9,211 deaths due to respiratory diseases in 2024, up from 8,801 in 2023, continuing an upward trend seen over the past few years, according…

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Over 9,000 deaths due to respiratory diseases in Delhi

Over 9,000 deaths due to respiratory diseases in Delhi

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab